MYCN and pancreatic neuroendocrine tumor: When solitary MYCN expression is driven under the control of the hGFAP promoter [19], transgenic mice (hGFAP-cre::lsl-MYCN) develop neuroendocrine tumors of the pancreas and pituitary adenomas.